Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Asia Pharma ExpoAsia Pharma Expo
Not Confirmed
Not Confirmed
29-31 March, 2026
Bio-Europe SpringBio-Europe Spring
Not Confirmed
Not Confirmed
31 March-01 April, 2026
Nutri Ingredients Summ...Nutri Ingredients Summit
Not Confirmed
Not Confirmed
31 March-01 April, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Asia Pharma ExpoAsia Pharma Expo
Industry Trade Show
Not Confirmed
29-31 March, 2026
Bio-Europe SpringBio-Europe Spring
Industry Trade Show
Not Confirmed
31 March-01 April, 2026
Nutri Ingredients Summ...Nutri Ingredients Summit
Industry Trade Show
Not Confirmed
31 March-01 April, 2026
Digital content

28 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/28/3264182/0/en/Arcutis-Presents-New-Phase-2-Results-in-Infants-with-Atopic-Dermatitis-in-Late-Breaking-Session-Today-at-the-2026-American-Academy-of-Dermatology-Annual-Meeting.html

18 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/18/3258097/0/en/Arcutis-to-Present-New-Clinical-Data-in-a-Late-Breaking-Podium-Presentation-and-Scientific-Posters-at-the-2026-American-Academy-of-Dermatology-Annual-Meeting.html

10 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/10/3252886/0/en/Arcutis-Announces-Publication-of-Positive-Long-Term-Safety-and-Efficacy-Data-with-ZORYVE-roflumilast-Cream-0-05-for-Treatment-of-Mild-to-Moderate-Atopic-Dermatitis-in-Children-Ages.html

05 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/05/3250243/0/en/Arcutis-Announces-Promotion-of-Mas-Matsuda-to-Executive-Vice-President-and-Chief-Legal-Officer-to-Support-Next-Phase-of-Growth.html

03 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/03/3248270/0/en/Arcutis-Begins-Enrolling-Phase-1a-1b-Study-Evaluating-ARQ-234-a-CD200R-Agonist-in-Healthy-Volunteers-and-Adults-With-Atopic-Dermatitis.html

27 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/27/3246782/0/en/Arcutis-Management-to-Present-at-TD-Cowen-s-46th-Annual-Health-Care-Conference.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE